Hydroxychloroquine in patients with novel coronavirus infection (COVID-19): a case-control study.

Author: AkopyanZ A, BegrambekovaYu L, KamalovA A, MareevV Yu, MareevYu V, MershinaE A, OrlovaYa A, PakhomovP V, PlisykA G

Paper Details 
Original Abstract of the Article :
Actuality One of the most widely discussed treatments for patients with COVID-19, especially at the beginning of the epidemy, was the use of the antimalarial drug hydroxychloroquine (HCQ). The first small non-randomized trials showed the ability of HCQ and its combination with azithromycin to accele...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://doi.org/10.18087/cardio.2021.2.n1548

データ提供:米国国立医学図書館(NLM)

Hydroxychloroquine for COVID-19: A Controversial Treatment

This research examines the potential effectiveness of hydroxychloroquine (HCQ), an antimalarial drug, in treating COVID-19. The study conducted a case-control study, comparing the outcomes of patients who received HCQ to those who did not. The results suggest that HCQ does not improve the severity of COVID-19 and may even slow recovery time and prolong hospitalization. This finding challenges earlier reports suggesting HCQ's efficacy and highlights the importance of rigorous scientific evidence in guiding treatment decisions.

Hydroxychloroquine: A Mirage in the Desert of COVID-19 Treatment

This research provides a sobering reminder that not all promising treatments live up to expectations. It's like encountering a mirage in the desert, where a seemingly refreshing oasis turns out to be an illusion. The study's findings suggest that HCQ may not be an effective treatment for COVID-19 and may even have negative consequences, highlighting the importance of careful evaluation and evidence-based medicine in navigating the complex landscape of disease treatment.

Navigating the COVID-19 Desert: A Need for Evidence-Based Medicine

This research underscores the importance of relying on rigorous scientific evidence when choosing treatment options for diseases like COVID-19. It's like navigating a challenging desert landscape, where the right compass and guide are essential for safe passage. The study's findings suggest that HCQ may not be the answer for COVID-19, emphasizing the need for a cautious and evidence-based approach to managing this disease.

Dr. Camel's Conclusion

This research highlights the importance of evidence-based medicine in navigating the complex landscape of disease treatment. It's like navigating a challenging desert landscape, where the right compass and guide are essential for safe passage. The study's findings underscore the importance of relying on rigorous scientific evidence and avoiding quick fixes when choosing treatment options for diseases like COVID-19.

Date :
  1. Date Completed 2021-03-22
  2. Date Revised 2022-12-07
Further Info :

Pubmed ID

33734044

DOI: Digital Object Identifier

10.18087/cardio.2021.2.n1548

Related Literature

SNS
PICO Info
in preparation
Languages

Russian

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.